| Danny Sean Julian, MD | |
|
2100 Lake Shore Dr, Waco, TX 76708-1271 | |
| (254) 755-0088 | |
| (254) 755-6695 |
| Full Name | Danny Sean Julian |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 27 Years |
| Location | 2100 Lake Shore Dr, Waco, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588645931 | NPI | - | NPPES |
| 152262501 | Medicaid | TX | |
| 116307304 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | K5574 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Home Care | Waco, TX | Home health agency |
| Providence Health Center | Waco, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health Alliance | 6305731068 | 129 |
News Archive
Efforts to renew the COBRA subsidy extension to help workers who have been recently laid off afford to keep their former employer's health insurance remains in limbo as lawmakers work at a measured pace to extend unemployment benefits and a tax package.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the U.S. Food and Drug Administration (FDA) has accepted and filed for review Genentech's new drug application (NDA) for vismodegib for the treatment of adults with advanced basal cell carcinoma (BCC) for whom surgery is considered inappropriate.
Revolutions Medical Corporation begins collaboration with H. Keith Brown, PhD, Philadelphia College of Osteopathic Medicine, on two clinical applications using their proprietary Magnetic Resonance software tools; RevDisplay, RevColor and Rev3D. One clinical application is for the differentiation and characterization of Intracranial Hemorrhages by Color MRI Automatic Segmentation and the other is for characterization of intracranial masses by Color MRI Automatic Segmentation.
Levothyroxine is taken by more than 13 million Americans to treat an underactive thyroid, thyroid gland enlargement, nodules, or cancer. In June, the Food and Drug Administration (FDA) ruled that several generic levothyroxine preparations had the same clinical effect and safety profile as certain branded products.
› Verified 1 days ago
| Entity Name | Providence Health Alliance |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932210838 PECOS PAC ID: 6305731068 Enrollment ID: O20040220000307 |
News Archive
Efforts to renew the COBRA subsidy extension to help workers who have been recently laid off afford to keep their former employer's health insurance remains in limbo as lawmakers work at a measured pace to extend unemployment benefits and a tax package.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the U.S. Food and Drug Administration (FDA) has accepted and filed for review Genentech's new drug application (NDA) for vismodegib for the treatment of adults with advanced basal cell carcinoma (BCC) for whom surgery is considered inappropriate.
Revolutions Medical Corporation begins collaboration with H. Keith Brown, PhD, Philadelphia College of Osteopathic Medicine, on two clinical applications using their proprietary Magnetic Resonance software tools; RevDisplay, RevColor and Rev3D. One clinical application is for the differentiation and characterization of Intracranial Hemorrhages by Color MRI Automatic Segmentation and the other is for characterization of intracranial masses by Color MRI Automatic Segmentation.
Levothyroxine is taken by more than 13 million Americans to treat an underactive thyroid, thyroid gland enlargement, nodules, or cancer. In June, the Food and Drug Administration (FDA) ruled that several generic levothyroxine preparations had the same clinical effect and safety profile as certain branded products.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Danny Sean Julian, MD 9510 Casa Grande Dr, Woodway, TX 76712-6481 Ph: (254) 723-3915 | Danny Sean Julian, MD 2100 Lake Shore Dr, Waco, TX 76708-1271 Ph: (254) 755-0088 |
News Archive
Efforts to renew the COBRA subsidy extension to help workers who have been recently laid off afford to keep their former employer's health insurance remains in limbo as lawmakers work at a measured pace to extend unemployment benefits and a tax package.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the U.S. Food and Drug Administration (FDA) has accepted and filed for review Genentech's new drug application (NDA) for vismodegib for the treatment of adults with advanced basal cell carcinoma (BCC) for whom surgery is considered inappropriate.
Revolutions Medical Corporation begins collaboration with H. Keith Brown, PhD, Philadelphia College of Osteopathic Medicine, on two clinical applications using their proprietary Magnetic Resonance software tools; RevDisplay, RevColor and Rev3D. One clinical application is for the differentiation and characterization of Intracranial Hemorrhages by Color MRI Automatic Segmentation and the other is for characterization of intracranial masses by Color MRI Automatic Segmentation.
Levothyroxine is taken by more than 13 million Americans to treat an underactive thyroid, thyroid gland enlargement, nodules, or cancer. In June, the Food and Drug Administration (FDA) ruled that several generic levothyroxine preparations had the same clinical effect and safety profile as certain branded products.
› Verified 1 days ago
Allison L Hulme, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1600 Providence Dr, Waco, TX 76707 Phone: 254-750-8200 Fax: 254-750-8326 | |
Timothy Martindale, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7104 New Sanger Rd, Waco, TX 76712 Phone: 254-741-1113 Fax: 254-741-1342 | |
Dr. Brian Douglas Bull, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 851 North Loop 340, Waco, TX 76705 Phone: 254-202-7500 Fax: 254-202-7599 | |
Dr. Matthew R Porter, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 W. State Hwy 6, Waco, TX 76712 Phone: 254-313-6700 Fax: 254-313-4531 | |
Lianda Mirella Martinez, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Franklin Ave, Suite B-c, Waco, TX 76701 Phone: 254-537-6590 Fax: 254-537-6599 | |
Jacob Lutgen, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1600 Providence Dr, Waco, TX 76707 Phone: 254-313-4200 | |
Dr. Aman A Shah, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Hillcrest Medical Blvd, Waco, TX 76712 Phone: 254-202-2000 |